Alessandro Vairelli, CEO of Microchannel Devices (MCD), has completed the path that led his idea to become a reality in a few years, despite the difficulties and slowdowns experienced in the last two years due to the well-known external factors-pandemic first and war later-that are affecting the global economy. The
1000 Pharmacies unveils new brand identity 1000 Pharmacies, the startup in the LIFTT portfolio launched in September 2020 by Nicolò Petrone, together with his two co-founders Mohamed Younes and Alberto Marchetti, was created to offer a simpler online pharmacy experience that could be used by millions of people. The mission
The event dedicated to innovation and the discovery of the ‘Italian Tech Unicorn’ hosted in that iconic ‘forge of ideas’ represented by the OGR in Turin, took place on 29 and 30 September. In this very intense two days, startuppers, investors, institutions, companies and media pooled ideas, opportunities, perspectives, to
“Aria Sensing’s goal is to design an innovative UWB radar integrated circuit for detecting people and objects by combining the best features of different existing technologies.” A radar integrated in a chip capable of intercepting any human movement or presence, starting with breathing or heartbeat. A system of ‘Human Centric’
The applications of modern radar are many and shape our daily lives in ways that are not always obvious. The antennas that will give us 5G and 6G internet coverage are electronically scanning antennas. The weather forecasts we consult would not exist without ground and space-based radars. Radars are also
“The innovation made by Careglance allows for a much faster surface analysis speed as well as considerably reducing the size of the OCT device.” LIFTT is participating with a EUR 250,000 investment in Care Glance, a deep tech start-up operating in the field of micro-optical diagnostics, which has developed and
“BetaGlue brings together some of the world’s excellence in the field of cancer fighting, and their insight to combine existing and already active technologies in the market in an innovative way is simply formidable.”This month, we announced our investment in BetaGlue Technologies, a highly innovative life science company that we
Arthrosis, a disease that is constantly increasing and has a high social cost.Osteoarthritis (OA) is one of the most common chronic diseases and underestimated by those who do not suffer from it, characterised by intense pain with little tendency to resolve and consequent reduced mobility. Osteoarthritis (OA) affects about 250
“When our inventors discovered that fat had prodigious effects in plastic surgery when placed under the skin, they thought of applying it to other areas.” It is Giorgio Ninzoli, CEO of Lipogems, who tells us how the device that could be the game changer against one of the most widespread
VAT n. 12013790014
Shared Capital
€ 100.835.954,00 authorised,
€ 60.223.243,00 paid,
€ 60.223.243,00 as per last statutory financial statements.
LIFTT S.p.A. adopts an Organization, Management and Control Model in line with the provisions of Legislative Decree 231/2001, and the Code of Ethics as completing part of the Model.